Cargando…

Virological and genomic analysis of SARS-CoV-2 from a favipiravir clinical trial cohort

INTRODUCTION: Several clinical studies have reported the efficacy of favipiravir in reducing viral load and shortening the duration of symptoms. However, the viability of SARS-CoV-2 in the context of favipiravir therapy and the potential for resistance development is unclear. METHODS: We sequenced S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Masahiro, Imai, Takumi, Sakurai, Aki, Komoto, Satoshi, Ide, Tomihiko, Lim, Chang Kweng, Shintani, Ayumi, Doi, Yohei, Murata, Takayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196299/ https://www.ncbi.nlm.nih.gov/pubmed/34176716 http://dx.doi.org/10.1016/j.jiac.2021.06.010

Ejemplares similares

Shedding of Viable Virus in Asymptomatic SARS-CoV-2 Carriers
por: Murata, Takayuki, et al.
Publicado: (2021)

A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19
por: Doi, Yohei, et al.
Publicado: (2020)

Porcine Rotavirus Closely Related to Novel Group of Human Rotaviruses
por: Wakuda, Mitsutaka, et al.
Publicado: (2011)

Lung Pathology of Mutually Exclusive Co-infection with SARS-CoV-2 and Streptococcus pneumoniae
por: Tsukamoto, Tetsuya, et al.
Publicado: (2021)

Favipiravir for symptomatic COVID-19: A nationwide observational cohort study
por: Doi, Yohei, et al.
Publicado: (2023)

Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure
por: Shindo, Yuichiro, et al.
Publicado: (2021)

Favipiravir use for SARS CoV-2 infection
por: Boretti, Alberto
Publicado: (2020)

Reassortment of Human and Animal Rotavirus Gene Segments in Emerging DS-1-Like G1P[8] Rotavirus Strains
por: Komoto, Satoshi, et al.
Publicado: (2016)

Longitudinal Analysis of Neutralizing Potency against SARS-CoV-2 in the Recovered Patients after Treatment with or without Favipiravir
por: Shinada, Kanako, et al.
Publicado: (2022)

Full Genome Characterization of Novel DS-1-Like G8P[8] Rotavirus Strains that Have Emerged in Thailand: Reassortment of Bovine and Human Rotavirus Gene Segments in Emerging DS-1-Like Intergenogroup Reassortant Strains
por: Tacharoenmuang, Ratana, et al.
Publicado: (2016)

Epstein-Barr virus: the molecular virology and the associated diseases
por: Murata, Takayuki
Publicado: (2023)

Structural Basis of SARS-CoV-2 Polymerase Inhibition by Favipiravir
por: Peng, Qi, et al.
Publicado: (2021)

Suspected cholestatic liver injury induced by favipiravir in a patient with COVID-19
por: Yamazaki, Shingo, et al.
Publicado: (2021)

Genome evolution of SARS-CoV-2 and its virological characteristics
por: Nakagawa, So, et al.
Publicado: (2020)

Natural History of Asymptomatic SARS-CoV-2 Infection
por: Sakurai, Aki, et al.
Publicado: (2020)

Human Rotavirus Reverse Genetics Systems to Study Viral Replication and Pathogenesis
por: Komoto, Satoshi, et al.
Publicado: (2021)

Model of the RNA Polymerase Complex of the SARS-CoV-2 Virus with Favipiravir
por: Polyakov, I. V., et al.
Publicado: (2021)

Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia
por: Solaymani-Dodaran, Masoud, et al.
Publicado: (2021)

Correction to: Genome evolution of SARS-CoV-2 and its virological characteristics
por: Nakagawa, So, et al.
Publicado: (2020)

Emergence and Characterization of Unusual DS-1-Like G1P[8] Rotavirus Strains in Children with Diarrhea in Thailand
por: Komoto, Satoshi, et al.
Publicado: (2015)

Whole Genomic Analysis of an Unusual Human G6P[14] Rotavirus Strain Isolated from a Child with Diarrhea in Thailand: Evidence for Bovine-To-Human Interspecies Transmission and Reassortment Events
por: Tacharoenmuang, Ratana, et al.
Publicado: (2015)

Transmission of NDM-5-Producing and OXA-48-Producing Escherichia coli Sequence Type 648 by International Visitors without Previous Medical Exposure
por: Harada, Sohei, et al.
Publicado: (2021)

SARS-CoV-2 Virology
por: Li, Yijia, et al.
Publicado: (2022)

Baseline uric acid levels and steady-state favipiravir concentrations are associated with occurrence of hyperuricemia among COVID-19 patients
por: Koseki, Takenao, et al.
Publicado: (2022)

Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase
por: Shannon, A., et al.
Publicado: (2020)

Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model
por: Driouich, Jean-Sélim, et al.
Publicado: (2021)

Mechanism of action of favipiravir against SARS-CoV-2: Mutagenesis or chain termination?
por: Zhao, Lei, et al.
Publicado: (2021)

Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
por: Negru, Paul Andrei, et al.
Publicado: (2022)

Comment on: Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia
por: Hashemian, Seyed MohammadReza, et al.
Publicado: (2022)

ICU admission and favipiravir
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
por: Chiba, Shiho, et al.
Publicado: (2022)

Serological Testing Reveals the Hidden COVID-19 Burden among Health Care Workers Experiencing a SARS-CoV-2 Nosocomial Outbreak
por: Nakagama, Yu, et al.
Publicado: (2021)

Susceptibility of Type I Interferon Receptor Knock-Out Mice to Heartland Bandavirus (HRTV) Infection and Efficacy of Favipiravir and Ribavirin in the Treatment of the Mice Infected with HRTV
por: Fujii, Hikaru, et al.
Publicado: (2022)

Basic virology of SARS-CoV 2
por: Ravi, V., et al.
Publicado: (2022)

Favipiravir and the Need for Early Ambulatory Treatment of SARS-CoV-2 Infection (COVID-19)
por: McCullough, Peter A.
Publicado: (2020)

Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP
por: Naydenova, Katerina, et al.
Publicado: (2021)

Favipiravir: Lack of efficacy during the treatment with SARS-CoV-2 pneumonia: case report
Publicado: (2022)

Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma
por: Hagimoto, Hiroki, et al.
Publicado: (2020)

Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
por: Yamasoba, Daichi, et al.
Publicado: (2022)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_21r5jne493o97tqas7dj02qv8p